ODYSSEY Alternative Trials Show Promise for Hypercholesterolemia Patients

Video

For patients with a statin intolerance, getting the treatment they need to manage their cholesterol levels can be difficult. A recent study has shown that a new class of drugs known as PCSK9 inhibitors could help effectively manage cholesterol levels in this patient population.

For patients with a statin intolerance, getting the treatment they need to manage their cholesterol levels can be difficult. A recent study has shown that a new class of drugs known as PCSK9 inhibitors could help effectively manage cholesterol levels in this patient population..

Patrick Moriarty, MD, FACC, FACP, from the University of Kansas Medical Center, presented findings from the Phase 3 alirocumab ODYSSEY trial during the 2014 American Heart Association Scientific Sessions in Chicago, IL.

Related Videos
Deepak Bhatt, MD, MPH | Credit: Mount Sinai
Robert Wood, MD | Credit: LinkedIn
Marla Dubinsky, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.